Status:
COMPLETED
Preventing Weight Gain Among Those Who Decline Behavioral Weight Loss Treatment (STEADY)
Lead Sponsor:
University of Florida
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Overweight and Obesity
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this pilot trial is to pilot test an intervention to help prevent weight gain or produce weight loss among adults with obesity. Participants are asked to self-weigh on a smart scale for on...
Detailed Description
To prevent weight gain while overcoming these common barriers to engaging in weight management interventions, we propose an intervention that prescribes self-weighing but does not prescribe changes in...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age 18-70
- Body weight recorded in EHR in the prior month from a primary care setting.
- Last BMI in EHR either ≥30 kg/m2 or between 25.0-29.9 kg/m2 with documented weight-related comorbidity (hypertension, type II diabetes, pre-diabetes, dyslipidemia, sleep apnea).
- Weight ≤ 375 lbs.
- Self-report sending and receiving at least one text message per month for past 6 months.
- Not currently enrolled in comprehensive behavioral weight loss treatment.
- Respond "no" to question asking if they would like to enroll in a comprehensive weight loss program in the next month
- Has not engaged in self-weighing ≥ 5 times per week on average over prior month.
- Not pregnant, breastfeeding, or planning to become pregnant in next 6 months.
- Not currently undergoing radiation or chemotherapy for cancer.
- No history of eating disorders.
- Interested in enrolling in low-burden self-weighing intervention.
- Able to read and understand English without help
- Exclusion criteria:
- History of Congestive Heart Failure or heart attack in past 6 months.
- Planning to move out of the region in the following 12 months
- Answer incorrectly on an attention check/ validation survey item
Exclusion
Key Trial Info
Start Date :
April 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2023
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT04751656
Start Date
April 16 2021
End Date
January 31 2023
Last Update
January 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UF Health at the University of Florida
Gainesville, Florida, United States, 32610